RecruitingNot ApplicableNCT06286774

Sleep as a Mechanism of Change in Alcohol Use

Sleep as a Mechanism of Change in Alcohol Use Outcomes Among Heavy-Drinking Adults


Sponsor

University of Missouri-Columbia

Enrollment

256 participants

Start Date

Mar 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to evaluate improvement of insomnia as a mechanism of improvement in alcohol use outcomes.


Eligibility

Min Age: 18 YearsMax Age: 49 Years

Inclusion Criteria3

  • report heavy drinking in a typical week in the past month
  • meet DSM-5 criteria for Alcohol Use Disorder
  • meet DSM-5 and research diagnostic criteria for Insomnia Disorder

Exclusion Criteria6

  • ≥50 years
  • unable to provide informed consent
  • report contraindications for CBT-I (mania or seizure disorder)
  • moderate to severe sleep apnea that is untreated
  • have symptoms requiring immediate clinical attention (e.g., psychosis, suicide plan)
  • are already receiving behavioral treatment for insomnia or alcohol use

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCognitive Behavioral Therapy for Insomnia

Cognitive Behavioral Therapy for Insomnia (CBT-I). Participants assigned to the CBT-I condition will attend 1-hour individual sessions of CBT-I once a week for five weeks. Consistent with clinical guidelines (Schutte-Rodin, Broch, Buysse, Dorsey, \& Sateia, 2008), treatment will include stimulus control (e.g., limit use of bed to sleep or sexual activity, get out of bed if lying awake for more than 20 minutes), sleep restriction (limit time in bed to amount of time spent sleeping on a typical night), sleep hygiene (e.g., avoid exercise within 2 hours of bedtime, create cool and dark sleep environment), relaxation training, and cognitive restructuring.


Locations(1)

University of Missouri-Columbia

Columbia, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06286774


Related Trials